Real-time monitoring of influenza virus production kinetics in HEK293 cell cultures

Biotechnology Progress

Volumn 29, Issue 1, 2013, Pages 275-284

  Emma, Petiot ^a   Kamen, Amine ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Cell culture; In process monitoring; Influenza; Kinetics; Vaccines

Indexed keywords

BIOPROCESSING; CELL POPULATIONS; CELL-BASED; CRITICAL TIME; HEK293 CELLS; HIGH MULTIPLICITY; IMMUNOLABELING; IN-LINE MONITORING; IN-PROCESS MONITORING; INFLUENZA; INFLUENZA VACCINES; INFLUENZA VIRUS; MAMMALIAN CELL CULTURE; MULTI FREQUENCY; PRODUCTION KINETICS; PROTEIN SYNTHESIS; REAL TIME MONITORING; REPLICATION KINETICS; VACCINE INDUSTRY; VIRAL PRODUCTION;

ANIMAL CELL CULTURE; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; ENZYME KINETICS; PROCESS MONITORING; PRODUCTION ENGINEERING; VACCINES; VIRUSES;

KINETICS;

ARTICLE; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN HEK293; GROWTH, DEVELOPMENT AND AGING; HUMAN; KINETICS; METABOLISM; ORTHOMYXOVIRUS; TIME;

CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; HEK293 CELLS; HUMANS; KINETICS; ORTHOMYXOVIRIDAE; TIME FACTORS;

MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 84873279360     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1601     Document Type: Article

References (72)

1. Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. Kinetics of influenza A virus infection in humans. J Virol. 2006; 80: 7590-7599.
2. Canini L, Carrat F. Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics. J Virol. 2011; 85: 2764-2770.
3. Smith AM, Perelson AS. Influenza A virus infection kinetics: quantitative data and models. Wiley Interdiscip Rev Syst Biol Med. 2011; 3: 429-445.
4. Smith AM, Adler FR, McAuley JL, Gutenkunst RN, Ribeiro RN, McCullers JA, Perelson AS. Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Comput Biol. 2011; 7: 1-8.
5. Beauchemin CAA, Handel A. A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead. BMC Public Health. 2011; 11(S7): 1-15.
6. Samji T. Influenza A: understanding the viral life cycle. Yale J Biol Med. 2009; 82: 153-159.
7. Nayak DP, Hui EK-W, Barman S. Assembly and budding of influenza virus. Virus Res. 2004; 106: 147-165.
8. Nayak DP, Balogun RA, Yamada H, Zhou ZH, Barman S. Influenza virus morphogenesis and budding. Virus Res. 2009; 143: 147-161.
9. Rossman JS, Lamb RA. Influenza virus assembly and budding. Virology. 2011; 411: 229-236.
10. Lai JCC, Chan WWL, Kien FF, Nicholls JM, Peiris JS, Garcia JM. Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase. J Gen Virol. 2010; 91: 2022-2030.
11. Brydon EWA, Morris SJ, Sweet C. Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev. 2005; 29: 837-850.
12. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol. 1993; 74: 2347-2355.
13. Oh S, Eichelberger MC. Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells. J Virol. 2000; 74: 7738-7744.
14. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol. 1994; 68: 3667-3673.
15. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melén K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 2001; 12: 171-180.
16. Ludwig S, Pleschka S, Planz O, Wolff T. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol. 2006; 8: 375-386.
17. Wurzer WJ, Ehrhardt C, Pleschka S, Berberich-Siebelt F, Wolff T, Walczak H, Planz O, Ludwig S. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem. 2004; 279: 30931-30937.
18. Doroshenko A, Halperin SA. Trivalent MDCK cell culture-derived influenza vaccine Optaflu(R) (Novartis Vaccines). Expert Rev Vaccines. 2009; 8: 679-688.
19. Patriarca P. Use of Cell Lines for the Production of Influenza Virus Vaccines: An Appraisal of Technical, Manufacturing, and Regulatory Considerations. World Health Organization; Alexendria, VA, USA, 2007; 1-12.
20. Heynisch B, Frensing T, Heinze K, Seitz C, Reichl U. Differential activation of host cell signalling pathways through infection with two variants of influenza A/Puerto Rico/8/34 (H1N1) in MDCK cells. Vaccine. 2010; 28: 8210-8218.
21. Schulze-Horsel J, Schulze M, Agalaridis G, Genzel Y, Reichl U. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-flow cytometry and mathematical modeling. Vaccine. 2009; 27: 2712-2722.
22. Lohr V, Rath A, Genzel Y, Jordan I, Sandig V, Reichl U. New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine. 2009; 27: 4975-4982.
23. Bleckwenn NA, Bentley WEB, Shiloach J. Evaluation of production parameters with the vaccinia virus expression system using microcarrier attached HeLa cells. Biotechnol Prog. 2005; 21: 554-561.
24. Wu SC, Huang GYL, Liu JH. Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture. Biotechnol Prog. 2002; 18: 617-622.
25. Audsley JM, Tannock GA. The growth of attenuated influenza vaccine donor strains in continuous cell lines. J Virol Methods. 2005; 123: 187-193.
26. Aggarwal K, Jing F, Maranga L, Liu J. Bioprocess optimization for cell culture based influenza vaccine production. Vaccine. 2011; 29: 3320-3328.
27. Opel CF, Li J, Amanullah A. Quantitative modeling of viable cell density, cell size, intracellular conductivity, and membrane capacitance in batch and fed-batch CHO processes using dielectric spectroscopy. Biotechnol Prog. 2010; 26: 1187-1199.
28. Tibayrenc P, Preziosi-Belloy L, Ghommidh C. On-line monitoring of dielectrical properties of yeast cells during a stress-model alcoholic fermentation. Process Biochem. 2011; 46: 193-201.
29. Ducommun P, Kadouri A, von Stockar U, Marison IW. On-line determination of animal cell concentration in two industrial high-density culture processes by dielectric spectroscopy. Biotechnol Bioeng. 2002; 77: 316-323.
30. Ducommun P, Ruffieux PA, Kadouri A, von Stockar U, Marison IW. Monitoring of temperature effects on animal cell metabolism in a packed bed process. Biotechnol Bioeng. 2002; 77: 838-842.
31. Sarrafzadeh MH, Belloy L, Esteban G, Navarro JM, Ghommidh C. Dielectric monitoring of growth and sporulation of Bacillus thuringiensis. Biotechnol Lett. 2005; 27: 511-517.
32. Ansorge S, Esteban G, Schmid G. On-line monitoring of infected Sf-9 insect cell cultures by scanning permittivity measurements and comparison with off-line biovolume measurements. Cytotechnology. 2007; 55: 115-124.
33. Negrete A, Esteban G, Kotin RM. Process optimization of large-scale production of recombinant adeno-associated vectors using dielectric spectroscopy. Appl Microbiol Biotechnol. 2007; 76: 761-772.
34. Ansorge S, Esteban G, Schmid G. On-line monitoring of nutrient feed additions by multi-frequency permittivity measurements in fed-batch cultivations of CHO cells. Cytotechnology. 2010; 62: 121-132.
35. Ansorge S, Esteban G, Schmid G. Multifrequency permittivity measurements enable on-line monitoring of changes in intracellular conductivity due to nutrient limitations during batch cultivations of CHO cells. Biotechnol Prog. 2010; 26: 272-283.
36. Ansorge S, Lanthier SS, Transfiguracion J, Durocher Y, Henry O, Kamen AA. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. J Gene Med. 2009; 11: 868-876.
37. Zeiser A, Bédard C, Voyer R, Jardin B, Tom R, Kamen AA. On-line monitoring of the progress of infection in Sf-9 insect cell cultures using relative permittivity measurements. Biotechnol Bioeng. 1999; 63: 122-126.
38. Ansorge S, Lanthier S, Transfiguracion J, Henry O, Kamen AA. Monitoring lentiviral vector production kinetics using online permittivity measurements. Biochem Eng J. 2011; 54: 16-25.
39. Côté J, Garnier A, Massie B, Kamen AA, Cote J. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnol Bioeng. 1998; 59: 567-575.
40. Le Ru A, Jacob D, Transfiguracion J, Ansorge S, Henry O, Kamen AA. Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine. 2010; 28: 3661-3671.
41. Petiot E, Jacob D, Lanthier S, Lohr V, Ansorge S, Kamen AA. Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnol. 2011; 11: 84-100.
42. Koester SK, Bolton WE. Intracellular markers. J Immunol Methods. 2000; 243: 99-106.
43. Genzel Y, Reichl U. Vaccine production. In: Portner R, editor. Humana press Inc., New York, NY, USA. Animal Cell Biotechnology: Methods and Protocol. 2007: 457-473.
44. Schwan HP. Electrical properties of tissue and cell suspensions. Adv Biol Med Phys. 1957; 5: 147-208.
45. Markx GH, Davey CL. The dielectric properties of biological cells at radiofrequencies: applications in biotechnology. Enzyme Microb Technol. 1999; 25: 161-171.
46. Lohr V, Genzel Y, Behrendt I, Scharfenberg K, Reichl U. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine. 2010; 28: 6256-6264.
47. Paillet C, Forno G, Soldano N, Kratje R, Etcheverrigaray M. Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero). Vaccine. 2011; 29: 7212-7217.
48. Rimmelzwaan GF, Baars MM, de Lijster P, Fouchier RA, Osterhaus AD. Inhibition of influenza virus replication by nitric oxide. J Virol. 1999; 73: 8880-8883.
49. Genzel Y, Olmer RM, Schafer B, Reichl U, Schäfer B. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Vaccine. 2006; 24: 6074-6087.
50. Pau MG, Ophorst C, Koldijk MH, Schouten G, Mehtali M, Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine. 2001; 19: 2716-2721.
51. Genzel Y, Fischer M, Reichl U. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine. 2006; 24: 3261-3272.
52. Hu AY-C, Weng T-C, Tseng Y-F, Chen YS, Wu CH, Hsiao S, Chou AH, Chao HJ, Gu A, Wu SC, Chong P, Lee MS. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine. 2008; 26: 5736-5740.
53. Genzel Y, Behrendt I, König S, Sann H, Reichl U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine. 2004; 22: 2202-2208.
54. Bock A, Schulze-Horsel J, Schwarzer J, Rapp E, Genzel Y, Reichl U. High-density microcarrier cell cultures for influenza virus production. Biotechnol Prog. 2011; 27: 241-250.
55. Frensing T, Seitz C, Heynisch B, Patzina C, Kochs G, Reichl U. Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells. Vaccine. 2011; 29: 7125-7129.
56. Rimmelzwaan GF, Baars M, Claas ECJ, Osterhaus AD. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods. 1998; 74: 57-66.
57. Matlin KS, Reggio H, Helenius A, Simons K. Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol. 1981; 91: 601-613.
58. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. Visualizing infection of individual influenza viruses. Proc Natl Acad Sci USA. 2003; 100: 9280-9285.
59. Möhler L, Flockerzi D, Sann H, Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol Bioeng. 2005; 90: 46-58.
60. Thompson K, Yin J. Population dynamics of an RNA virus and its defective interfering particles in passage cultures. Virol J. 2010; 7: 257-267.
61. Zimmermann D, Zhou A, Kiesel M, Feldbauer K, Terpitz U, Haase W, Schneider-Hohendorf T, Bamberg E, Sukhorukov VL. Effects on capacitance by overexpression of membrane proteins. Biochem Biophys Res Commun. 2008; 369: 1022-1026.
62. Zimmermann D, Terpitz U, Zhou A, Reuss R, Muller K, Sukhorukov VL, GeBner P, Nagel G, Zimmermann U, Bamberg E. Biophysical characterisation of electrofused giant HEK293-cells as a novel electrophysiological expression system. Biochem Biophys Res Commun. 2006; 348: 673-681.
63. Zeiser A, Elias CB, Voyer R, Jardin B, Kamen AA. On-line monitoring of physiological parameters of insect cell cultures during the growth and infection process. Biotechnol Prog. 2000; 16: 803-808.
64. Carvell JP, Dowd JE. On-line measurements and control of viable cell density in cell culture manufacturing processes using radio-frequency impedance. Cytotechnology. 2006; 50: 35-48.
65. Petiot E, El-Wajgali A, Esteban G, Geny C, Pinton H, Marc A. Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes. Cytotechnology. 2012.
66. Schultz-Cherry S, Krug RM, Hinshaw VS. Induction of apoptosis by influenza virus. Semin Virol. 1998; 495: 491-495.
67. Palomares L, Pedroza J, Ramirez O. Cell size as a tool to predict the production of recombinant protein by the insect-cell baculovirus expression system. Biotechnol Lett. 2001; 23: 359-364.
68. Chico E, Jäger V. Measurements of changes in cell size distribution to monitor Baculovirus infection of insect cells. In: Merten OW, Perrin P, Griffiths B, editors. New Developments and New Applications in Animal Cell Technology. Dordrecht: Kluwer Academic Publishers; 1998: 329-331.
69. Ksenofontov AL, Kozlovskii VS, Kordyukova LV, Radyukhin AV, Timofeeva AV, Dobrov EN. Determination of concentration and aggregate size in influenza virus preparations from true UV absorption spectra. Mol Biol. 2006; 40: 152-158.
70. Berdichevsky M, Gentile MP, Hughes B, Meis P, Peltier J, Blumentals I, Aunins J, Altaras NE. Establishment of higher passage PER.C6 cells for adenovirus manufacture. Biotechnol Prog. 2008; 24: 158-165.
71. Costin JM. Cytopathic mechanisms of HIV-1. Virol J. 2007; 4: 100-122.
72. Archer S, Morgan H, Rixon FJ. Electrorotation studies of baby hamster kidney fibroblasts infected with herpes simplex virus type 1. Biophys J. 1999; 76: 2833-2842.